Update of humanized animal disease models in studying Graft-versus-host disease

References

• Appelbaum FR. Haematopoietic cell transplantation as immunotherapy. Nature. 2001;411(6835):385–389. doi:10.1038/35077251.
   PubMed Web of Science ®Google Scholar
• Jacobsohn DA, Arora M, Klein JP, Hassebroek A, Flowers ME, Cutler CS, Urbano-Ispizua A, Bolwell BJ, Antin JH, Boyiadzis M, et al. Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease. Blood. 2011; 118(16):4472–4479. doi:10.1182/blood-2011-04-349068.
   PubMed Web of Science ®Google Scholar
• Blazar BR, Murphy WJ, Abedi M. Advances in graft-versus-host disease biology and therapy. Nat Reviews Immunol. 2012;12(6):443–458. doi:10.1038/nri3212.
   PubMed Web of Science ®Google Scholar
• Gupta V, Ball SE, Sage D, Ortin M, Freires M, Gordon-Smith EC, Marsh JC. Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning. Bone Marrow Transplant. 2005;35(5):467–471. doi:10.1038/sj.bmt.1704799.
   PubMed Web of Science ®Google Scholar
• Shlomchik WD. Graft-versus-host disease. Nat Reviews Immunol. 2007;7(5):340–352. doi:10.1038/nri2000.
   PubMed Web of Science ®Google Scholar
• Bleakley M, Riddell SR. Molecules and mechanisms of the graft-versus-leukaemia effect. Nature Rev Cancer. 2004;4(5):371–380. doi:10.1038/nrc1365.
   PubMed Web of Science ®Google Scholar
• Goker H, Haznedaroglu IC, Chao NJ. Acute graft-vs-host disease: pathobiology and management. Exp Hematol. 2001;29(3):259–277.
   PubMed Web of Science ®Google Scholar
• Cooke KR, Kobzik L, Martin TR, Brewer J, Delmonte J Jr., Crawford JM, Ferrara JL. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The Roles of Minor H Antigens and Endotoxin`. Blood. 1996;88(8):3230–3239.
   PubMed Web of Science ®Google Scholar
• Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet (London, England). 2009;373(9674):1550–1561. doi:10.1016/s0140-6736(09)60237-3.
   PubMed Web of Science ®Google Scholar
• Martin PJ, Rizzo JD, Wingard JR, Ballen K, Curtin PT, Cutler C, Litzow MR, Nieto Y, Savani BN, Schriber JR, et al. First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2012; 18(8):1150–1163. doi:10.1016/j.bbmt.2012.04.005.
   PubMed Web of Science ®Google Scholar
• Jagasia M, Greinix H, Robin M, Das-Gupta E, Jacobs R, Savani BN, Engelhardt BG, Kassim A, Worel N, Knobler R, et al. Extracorporeal photopheresis versus anticytokine therapy as a second-line treatment for steroid-refractory acute GVHD: a multicenter comparative analysis. Biol Blood Marrow Transplant. 2013; 19(7):1129–1133. doi:10.1016/j.bbmt.2013.04.018.
   PubMed Web of Science ®Google Scholar
• Kanda Y, Chiba S, Hirai H, Sakamaki H, Iseki T, Kodera Y, Karasuno T, Okamoto S, Hirabayashi N, Iwato K, et al. Allogeneic hematopoietic stem cell transplantation from family members other than HLA-identical siblings over the last decade (1991-2000). Blood. 2003; 102(4):1541–1547. doi:10.1182/blood-2003-02-0430.
   PubMed Web of Science ®Google Scholar
• Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M, Martin PJ, Sandmaier BM, Marr KA, Appelbaum FR, et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med. 2010; 363(22):2091–2101. doi:10.1056/NEJMoa1004383.
   PubMed Web of Science ®Google Scholar
• Lazarus HM. Acute leukemia in adults: novel allogeneic transplant strategies. Hematology (Amsterdam, Netherlands). 2012;17(Suppl 1):S47–51. doi:10.1179/102453312x13336169155493.
   PubMedGoogle Scholar
• Kalwak K, Moson I, Cwian J, Gorczynska E, Toporski J, Turkiewicz D, Latos-Grazynska E, Chybicka A. A prospective analysis of immune recovery in children following allogeneic transplantation of t-cell-depleted or non-T-cell-depleted hematopoietic cells from HLA-disparate family donors. Transplant Proc. 2003;35(4):1551–1555.
   PubMed Web of Science ®Google Scholar
• Tiberghien P, Ferrand C, Lioure B, Milpied N, Angonin R, Deconinck E, Certoux JM, Robinet E, Saas P, Petracca B et al. 2001. Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft. Blood. 97(1):63–72.
   PubMed Web of Science ®Google Scholar
• Gu J, Lu L, Chen M, Xu L, Lan Q, Li Q, Liu Z, Chen G, Wang P, X W, et al. TGF-beta-induced CD4+Foxp3+ T cells attenuate acute graft-versus-host disease by suppressing expansion and killing of effector CD8+ cells. J Immunol (Baltimore, Md 1950). 2014; 193(7):3388–3397. doi:10.4049/jimmunol.1400207.
   PubMed Web of Science ®Google Scholar
• Zheng SG, Wang JH, Koss MN, Quismorio F Jr., Gray JD, Horwitz DA. CD4+ and CD8+ regulatory T cells generated ex vivo with IL-2 and TGF-beta suppress a stimulatory graft-versus-host disease with a lupus-like syndrome. J Immunol (Baltimore, Md 1950). 2004;172(3):1531–1539.
   PubMed Web of Science ®Google Scholar
• Sung AD, Chao NJ. Concise review: acute graft-versus-host disease: immunobiology, prevention, and treatment. Stem Cells Transl Med. 2013;2(1):25–32. doi:10.5966/sctm.2012-0115.
   PubMed Web of Science ®Google Scholar
• Teshima T. JAK inhibitors: a home run for GVHD patients? Blood. 2014;123(24):3691–3693. doi:10.1182/blood-2014-04-570325.
   PubMed Web of Science ®Google Scholar
• Fiuza-Luces C, Garatachea N, Simpson RJ, Berger NA, Ramirez M, Lucia A. Understanding graft-versus-host disease. Preliminary findings regarding the effects of exercise in affected patients. Exerc Immunol Rev. 2015;21:80–112.
   PubMed Web of Science ®Google Scholar
• Zhong H, Liu Y, Xu Z, Liang P, Yang H, Zhang X, Zhao J, Chen J, Fu S, Tang Y, et al. TGF-beta-Induced CD8(+)CD103(+) regulatory T cells show potent therapeutic effect on chronic graft-versus-host disease lupus by suppressing B cells. Front Immunol. 2018;9:35. doi:10.3389/fimmu.2018.00035.
   PubMed Web of Science ®Google Scholar
• Hulsdunker J, Zeiser R. Insights into the pathogenesis of GvHD: what mice can teach us about man. Tissue Antigens. 2015;85(1):2–9. doi:10.1111/tan.12497.
   PubMedGoogle Scholar
• McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M, Weissman IL. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science (New York, NY). 1988;241(4873):1632–1639. doi:10.1126/science.2971269.
   Google Scholar
• Bosma GC, Custer RP, Bosma MJ. A severe combined immunodeficiency mutation in the mouse. Nature. 1983;301(5900):527–530.
   PubMed Web of Science ®Google Scholar
• Mosier DE, Gulizia RJ, Baird SM, Wilson DB. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature. 1988;335(6187):256–259. doi:10.1038/335256a0.
   PubMed Web of Science ®Google Scholar
• Hoffmann-Fezer G, Gall C, Zengerle U, Kranz B, Thierfelder S. Immunohistology and immunocytology of human T-cell chimerism and graft-versus-host disease in SCID mice. Blood. 1993;81(12):3440–3448.
   PubMed Web of Science ®Google Scholar
• Tary-Lehmann M, Saxon A, Lehmann PV. The human immune system in hu-PBL-SCID mice. Immunol Today. 1995;16(11):529–533. doi:10.1016/0167-5699(95)80046-8.
   PubMedGoogle Scholar
• Abedi MR, Christensson B, Islam KB, Hammarstrom L, Smith CI. Immunoglobulin production in severe combined immunodeficient (SCID) mice reconstituted with human peripheral blood mononuclear cells. Eur J Immunol. 1992;22(3):823–828. doi:10.1002/eji.1830220329.
   PubMed Web of Science ®Google Scholar
• Carballido JM, Namikawa R, Carballido-Perrig N, Antonenko S, Roncarolo MG, De Vries JE. Generation of primary antigen-specific human T- and B-cell responses in immunocompetent SCID-hu mice. Nat Med. 2000;6(1):103–106. doi:10.1038/71434.
   PubMed Web of Science ®Google Scholar
• Verlinden SF, Mulder AH, De Leeuw JP, Van Bekkum DW. T lymphocytes determine the development of xeno GVHD and of human hemopoiesis in NOD/SCID mice following human umbilical cord blood transplantation. Stem Cells (Dayton, Ohio). 1998;16(Suppl 1):205–217. doi:10.1002/stem.5530160825.
   PubMedGoogle Scholar
• Berney T, Molano RD, Pileggi A, Cattan P, Li H, Ricordi C, Inverardi L. Patterns of engraftment in different strains of immunodeficient mice reconstituted with human peripheral blood lymphocytes. Transplantation. 2001;72(1):133–140.
   PubMed Web of Science ®Google Scholar
• Williams SS, Umemoto T, Kida H, Repasky EA, Bankert RB. Engraftment of human peripheral blood leukocytes into severe combined immunodeficient mice results in the long term and dynamic production of human xenoreactive antibodies. J Immunol (Baltimore, Md 1950). 1992;149(8):2830–2836.
   PubMed Web of Science ®Google Scholar
• Lu L, Zhou X, Wang J, Zheng SG, Horwitz DA. Characterization of protective human CD4CD25 FOXP3 regulatory T cells generated with IL-2, TGF-beta and retinoic acid. PloS One. 2010;5(12):e15150. doi:10.1371/journal.pone.0015150.
   PubMed Web of Science ®Google Scholar
• Huang F, Chen M, Chen W, Gu J, Yuan J, Xue Y, Dang J, Su W, Wang J, Zadeh HH, et al. Human gingiva-derived mesenchymal stem cells inhibit xeno-graft-versus-host disease via CD39-CD73-adenosine and IDO signals. Front Immunol. 2017;8:68. doi:10.3389/fimmu.2017.00068.
   PubMed Web of Science ®Google Scholar
• Lu L, Q L, Li Z, Zhou X, Gu J, Q L, Wang J, Chen M, Liu Y, Shen Y, et al. Critical role of all-trans retinoic acid in stabilizing human natural regulatory T cells under inflammatory conditions. Proc Natl Acad Sci U S A. 2014; 111(33):E3432–40. doi:10.1073/pnas.1408780111.
   PubMed Web of Science ®Google Scholar
• Pflumio F, Lapidot T, Murdoch B, Patterson B, Dick JE. Engraftment of human lymphoid cells into newborn SCID mice leads to graft-versus-host disease. Int Immunol. 1993;5(12):1509–1522.
   PubMed Web of Science ®Google Scholar
• Leung W, Ramirez M, Mukherjee G, Perlman EJ, Civin CI. Comparisons of alloreactive potential of clinical hematopoietic grafts. Transplantation. 1999;68(5):628–635.
   PubMed Web of Science ®Google Scholar
• Sandhu JS, Gorczynski R, Shpitz B, Gallinger S, Nguyen HP, Hozumi N. A human model of xenogeneic graft-versus-host disease in SCID mice engrafted with human peripheral blood lymphocytes. Transplantation. 1995;60(2):179–184.
   PubMed Web of Science ®Google Scholar
• Huppes W, Hoffmann-Fezer G. Peripheral blood leukocyte grafts that induce human to mouse graft-vs.-host disease reject allogeneic human skin grafts. Am J Pathol. 1995;147(6):1708–1714.
   PubMed Web of Science ®Google Scholar
• Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, Tennent B, McKenna S, Mobraaten L, Rajan TV, Greiner DL et al. 1995. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol (Baltimore, Md 1950). 154(1):180–191.
   PubMed Web of Science ®Google Scholar
• Greiner DL, Shultz LD, Yates J, Appel MC, Perdrizet G, Hesselton RM, Schweitzer I, Beamer WG, Shultz KL, Pelsue SC et al. 1995. Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice. Am J Pathol. 146(4):888–902.
   PubMed Web of Science ®Google Scholar
• Gan OI, Murdoch B, Larochelle A, Dick JE. Differential maintenance of primitive human SCID-repopulating cells, clonogenic progenitors, and long-term culture-initiating cells after incubation on human bone marrow stromal cells. Blood. 1997;90(2):641–650.
   PubMed Web of Science ®Google Scholar
• Martino G, Anastasi J, Feng J, Mc Shan C, DeGroot L, Quintans J, Grimaldi LM. The fate of human peripheral blood lymphocytes after transplantation into SCID mice. Eur J Immunol. 1993;23(5):1023–1028. doi:10.1002/eji.1830230506.
   PubMed Web of Science ®Google Scholar
• Van Rijn RS, Simonetti ER, Hagenbeek A, Hogenes MC, De Weger RA, Canninga-Van Dijk MR, Weijer K, Spits H, Storm G, Van Bloois L, et al. A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2-/- gammac-/- double-mutant mice. Blood. 2003; 102(7):2522–2531. doi:10.1182/blood-2002-10-3241.
   PubMed Web of Science ®Google Scholar
• Ito R, Katano I, Kawai K, Hirata H, Ogura T, Kamisako T, Eto T, Ito M. Highly sensitive model for xenogenic GVHD using severe immunodeficient NOG mice. Transplantation. 2009;87(11):1654–1658. doi:10.1097/TP.0b013e3181a5cb07.
   PubMed Web of Science ®Google Scholar
• Ito R, Katano I, Kawai K, Yagoto M, Takahashi T, Ka Y, Ogura T, Takahashi R, Ito M, Novel Xenogeneic A. Graft-versus-host disease model for investigating the pathological role of human CD4(+) or CD8(+) T cells using immunodeficient NOG mice. Am J Transplant. 2017;17(5):1216–1228. doi:10.1111/ajt.14116.
   PubMed Web of Science ®Google Scholar
• Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K, Ueyama Y, Koyanagi Y, Sugamura K, Tsuji K, et al. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood. 2002; 100(9):3175–3182. doi:10.1182/blood-2001-12-0207.
   PubMed Web of Science ®Google Scholar
• Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, Chaleff S, Kotb M, Gillies SD, King M, Mangada J et al. 2005. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol (Baltimore, Md 1950). 174(10):6477–6489.
   PubMed Web of Science ®Google Scholar
• Ito R, Takahashi T, Katano I, Ito M. Current advances in humanized mouse models. Cell Mol Immunol. 2012;9(3):208–214. doi:10.1038/cmi.2012.2.
   PubMed Web of Science ®Google Scholar
• Hiramatsu H, Nishikomori R, Heike T, Ito M, Kobayashi K, Katamura K, Nakahata T. Complete reconstitution of human lymphocytes from cord blood CD34+ cells using the NOD/SCID/gammacnull mice model. Blood. 2003;102(3):873–880. doi:10.1182/blood-2002-09-2755.
   PubMed Web of Science ®Google Scholar
• Chijiwa T, Kawai K, Noguchi A, Sato H, Hayashi A, Cho H, Shiozawa M, Kishida T, Morinaga S, Yokose T, et al. Establishment of patient-derived cancer xenografts in immunodeficient NOG mice. Int J Oncol. 2015; 47(1):61–70. doi:10.3892/ijo.2015.2997.
   PubMed Web of Science ®Google Scholar
• Hasegawa M, Kawai K, Mitsui T, Taniguchi K, Monnai M, Wakui M, Ito M, Suematsu M, Peltz G, Nakamura M, et al. The reconstituted ‘humanized liver’ in TK-NOG mice is mature and functional. Biochem Biophys Res Commun. 2011; 405(3):405–410. doi:10.1016/j.bbrc.2011.01.042.
   PubMed Web of Science ®Google Scholar
• Sato K, Misawa N, Nie C, Satou Y, Iwakiri D, Matsuoka M, Takahashi R, Kuzushima K, Ito M, Takada K, et al. A novel animal model of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in humanized mice. Blood. 2011; 117(21):5663–5673. doi:10.1182/blood-2010-09-305979.
   PubMed Web of Science ®Google Scholar
• Serr I, Furst RW, Achenbach P, Scherm MG, Gokmen F, Haupt F, Sedlmeier EM, Knopff A, Shultz L, Willis RA, et al. Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice. Nat Commun. 2016;7:10991. doi:10.1038/ncomms10991.
   PubMed Web of Science ®Google Scholar
• Ito R, Takahashi T, Katano I, Kawai K, Kamisako T, Ogura T, Ida-Tanaka M, Suemizu H, Nunomura S, Ra C, et al. Establishment of a human allergy model using human IL-3/GM-CSF-transgenic NOG mice. J Immunol (Baltimore, Md 1950). 2013; 191(6):2890–2899. doi:10.4049/jimmunol.1203543.
   PubMed Web of Science ®Google Scholar
• Zanjani ED, Almeida-Porada G, Flake AW. The human/sheep xenograft model: a large animal model of human hematopoiesis. Int J Hematol. 1996;63(3):179–192.
   PubMed Web of Science ®Google Scholar
• Zanjani ED, Flake AW, Rice H, Hedrick M, Tavassoli M. Long-term repopulating ability of xenogeneic transplanted human fetal liver hematopoietic stem cells in sheep. J Clin Invest. 1994;93(3):1051–1055. doi:10.1172/jci117054.
   PubMed Web of Science ®Google Scholar
• Zanjani ED, Pallavicini MG, Ascensao JL, Flake AW, Langlois RG, Reitsma M, MacKintosh FR, Stutes D, Harrison MR, Tavassoli M. Engraftment and long-term expression of human fetal hemopoietic stem cells in sheep following transplantation in utero. J Clin Invest. 1992;89(4):1178–1188. doi:10.1172/jci115701.
   PubMed Web of Science ®Google Scholar
• Zanjani ED, Almeida-Porada G, Flake AW. Retention and multilineage expression of human hematopoietic stem cells in human-sheep chimeras. Stem Cells (Dayton, Ohio). 1995;13(2):101–111. doi:10.1002/stem.5530130202.
   PubMed Web of Science ®Google Scholar
• Li Y, Wang K, Cheng J, Li F, Ma Y, Yang Y. Human-pig spleen transplantation leading to high level of chimerism. Transplant Proc. 2000;32(5):1103–1104.
   PubMed Web of Science ®Google Scholar